Real-Time Three-Dimensional Echocardiography in Percutaneous Transcatheter Closure of Atrial Septal Aneurysm with Atrial Septal Defect in Pediatrics
Keywords:
atrial septal aneurysm, transcatheter, echocardiography, fluoroscopy, transesophagealAbstract
Background: ASA (atrial septal aneurysm) is redundant and mobile atrial septum. It accounts for 2-3% of population.
Aim: This study aims to evaluate the use of echocardiographic guidance in percutaneous closure of ASA.
Methods: It is a prospective cohort design on 60 ASD secondum children who were referred for transcatheter closure between february 2022 to february 2024 at catheterization labs of Tanta Teaching University Hospital, Tanta New Surgical Hospital and Alexandria Smouha Children University Hospital.
Results: Only 14 ASD cases were ASD with ASA and all underwent percutaneous closure successfully with different closure techniques with no risk of complications and deployment was done smoothly under three-dimensional echocardiography.
Conclusions: Three-dimensional echocardiography can help in closure of secondum ASD with ASA in children
Downloads
References
R. Atak, M. Ileri, S. Ozturk, A. Korkmaz, and E. Yetkin, “Echocardiographic Findings in Patients with Atrial Septal Aneurysm: A Prospective Case-Control Study,” Cardiol Res Pract, vol. 2019, pp. 1–7, Apr. 2019, doi: 10.1155/2019/3215765.
G. Turc, J.-Y. Lee, E. Brochet, J. S. Kim, J.-K. Song, and J.-L. Mas, “Atrial Septal Aneurysm, Shunt Size, and Recurrent Stroke Risk in Patients with Patent Foramen Ovale,” J Am Coll Cardiol, vol. 75, no. 18, pp. 2312–2320, May 2020, doi: 10.1016/j.jacc.2020.02.068.
F. E. Silvestry et al., “Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions,” Journal of the American Society of Echocardiography, vol. 28, no. 8, pp. 910–958, Aug. 2015, doi: 10.1016/j.echo.2015.05.015.
S. F. Arnautu et al., “A Review of the Role of Transthoracic and Transesophageal Echocardiography, Computed Tomography, and Magnetic Resonance Imaging in Cardioembolic Stroke.,” Med Sci Monit, vol. 28, p. e936365, Jun. 2022, doi: 10.12659/MSM.936365.
X. Wang et al., “An atrial septal aneurysm with an organized thrombus in an asymptomatic patient: A case report.,” Medicine, vol. 98, no. 48, p. e18074, Nov. 2019, doi: 10.1097/MD.0000000000018074.
A. M. Johri et al., “Real-time three-dimensional transesophageal echocardiography in patients with secundum atrial septal defects: outcomes following transcatheter closure.,” J Am Soc Echocardiogr, vol. 24, no. 4, pp. 431–7, Apr. 2011, doi: 10.1016/j.echo.2010.12.011.
J. A. Lodato et al., “Feasibility of real-time three-dimensional transoesophageal echocardiography for guidance of percutaneous atrial septal defect closure.,” Eur J Echocardiogr, vol. 10, no. 4, pp. 543–8, Jun. 2009, doi: 10.1093/ejechocard/jen337.
P. Acar et al., “Influence of atrial septal defect anatomy in patient selection and assessment of closure with the Cardioseal device; a three-dimensional transoesophageal echocardiographic reconstruction.,” Eur Heart J, vol. 21, no. 7, pp. 573–81, Apr. 2000, doi: 10.1053/euhj.1999.1855.
G. Tamborini et al., “Comparison of two- and three-dimensional transesophageal echocardiography in patients undergoing atrial septal closure with the amplatzer septal occluder.,” Am J Cardiol, vol. 90, no. 9, pp. 1025–8, Nov. 2002, doi: 10.1016/s0002-9149(02)02695-4.
M. Taniguchi et al., “Application of Real-Time Three-Dimensional Transesophageal Echocardiography Using a Matrix Array Probe for Transcatheter Closure of Atrial Septal Defect,” Journal of the American Society of Echocardiography, vol. 22, no. 10, pp. 1114–1120, Oct. 2009, doi: 10.1016/j.echo.2009.06.008.
W.-Z. Xu et al., “non-fluoroscopic percutaneous transcatheter closure of atrial septal defects in children under transesophageal echocardiographic guidance.,” World J Pediatr, vol. 14, no. 4, pp. 378–382, Aug. 2018, doi: 10.1007/s12519-018-0179-x.
J. M. Simpson and O. Miller, “Three-dimensional echocardiography in congenital heart disease,” Arch Cardiovasc Dis, vol. 104, no. 1, pp. 45–56, Jan. 2011, doi: 10.1016/j.acvd.2010.11.004.
A. Roushdy, A. El sayegh, Y. A. Ali, H. Attia, A. El fiky, and M. El sayed, “A novel three-dimensional echocardiographic method for device size selection in patients undergoing ASD trans-catheter closure,” The Egyptian Heart Journal, vol. 72, no. 1, p. 1, Dec. 2020, doi: 10.1186/s43044-019-0038-7.
S. K. Saha, C. M. Ahmed, T. Haque, M. A. Al Mamun, and M. Z. Hussain, “Assessment of atrial septal defects using 3-dimensional transthoracic echocardiography prior to percutaneous device closure: first report from Bangladesh,” Ther Adv Cardiovasc Dis, vol. 17, Jan. 2023, doi: 10.1177/17539447231193290.
A. Mani, S. Harikrishnan, B. Sasidharan, S. Ganapathi, and A. K. Valaparambil, “Utility of 3D Echocardiography for Device Sizing During Transcatheter ASD Closure: A Comparative Study.,” J Cardiovasc Imaging, vol. 31, no. 4, pp. 180–187, Oct. 2023, doi: 10.4250/jcvi.2023.0039.
F. Mehmood et al., “Usefulness of live three-dimensional transthoracic echocardiography in the characterization of atrial septal defects in adults,” Echocardiography, vol. 21, no. 8, pp. 707–713, Nov. 2004, doi: 10.1111/J.0742-2822.2004.40017. X.
B. Deng et al., “Assessment of atrial septal defect using 2D or real-time 3D transesophageal echocardiography and outcomes following transcatheter closure,” Ann Transl Med, vol. 9, no. 16, pp. 1309–1309, Aug. 2021, doi: 10.21037/atm-21-3206.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.